0001415889-24-006070.txt : 20240301 0001415889-24-006070.hdr.sgml : 20240301 20240301160524 ACCESSION NUMBER: 0001415889-24-006070 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240228 FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Busse Falko CENTRAL INDEX KEY: 0001739999 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 24709572 MAIL ADDRESS: STREET 1: 40 MANNING ROAD CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER CORP CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 978663-3660 MAIL ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP DATE OF NAME CHANGE: 20030721 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER DALTONICS INC DATE OF NAME CHANGE: 20000315 4 1 form4-03012024_040301.xml X0508 4 2024-02-28 0001109354 BRUKER CORP BRKR 0001739999 Busse Falko 40 MANNING ROAD BILLERICA MA 01821 false true false false PRESIDENT, BIOSPIN GROUP 0 Common Stock 2024-02-28 4 M 0 12000 19.82 A 44859 D Common Stock 2024-02-28 4 M 0 7097 22.19 A 51956 D Common Stock 2024-02-28 4 M 0 4384 34.02 A 56340 D Common Stock 2024-02-28 4 M 0 4641 41.95 A 60981 D Common Stock 2024-02-28 4 S 0 13852 86.06 D 47129 D Common Stock 2024-02-28 4 S 0 12770 84.97 D 34359 D Common Stock 2024-02-28 4 S 0 1500 84.48 D 32859 D Stock Option (Right to Purchase) 19.82 2024-02-28 4 M 0 12000 0 D 2025-08-07 Common Stock 12000 0 D Stock Option (Right to Purchase) 22.19 2024-02-28 4 M 0 7097 0 D 2026-10-04 Common Stock 7097 0 D Stock Option (Right to Purchase) 34.02 2024-02-28 4 M 0 4384 0 D 2028-08-09 Common Stock 4384 0 D Stock Option (Right to Purchase) 41.95 2024-02-28 4 M 0 4641 0 D 2029-08-08 Common Stock 4641 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.52 to $86.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.52 to $85.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.46 to $84.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. The stock option granted to the Reporting Person on August 9, 2018 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. The stock option granted to the Reporting Person on August 8, 2019 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. /s/ Michael A Simone, Attorney-in-Fact 2024-03-01